Intercept Pharmaceuticals, Inc.
ICPT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$175 | -$91 | -$275 | -$345 |
| Dep. & Amort. | $1 | $3 | $3 | $4 |
| Deferred Tax | $0 | -$12 | $4 | $2 |
| Stock-Based Comp. | $22 | $34 | $61 | $56 |
| Change in WC | $22 | -$14 | $2 | $19 |
| Other Non-Cash | $104 | $39 | $35 | $27 |
| Operating Cash Flow | -$27 | -$42 | -$170 | -$237 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$4 | -$1 |
| Net Acquisitions | $0 | -$71 | -$167 | $188 |
| Inv. Purchases | -$553 | -$349 | -$331 | -$603 |
| Inv. Sales/Matur. | $452 | $421 | $497 | $415 |
| Other Inv. Act. | $363 | $71 | $167 | -$188 |
| Investing Cash Flow | $262 | $71 | $163 | -$189 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $227 |
| Stock Repurch. | -$1 | -$76 | -$2 | -$2 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$267 | $1 | -$1 | $458 |
| Financing Cash Flow | -$267 | $1 | -$1 | $458 |
| Forex Effect | -$6 | -$1 | -$1 | -$0 |
| Net Chg. in Cash | -$39 | $29 | -$9 | $32 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94 | $66 | $75 | $43 |
| End Cash | $56 | $94 | $66 | $75 |
| Free Cash Flow | -$27 | -$42 | -$174 | -$238 |